Increasing Levels of Estradiol Are Deleterious to Embryonic Implantation Because They Directly Affect the Embryo
Overview
Affiliations
Objective: To investigate whether the deleterious effect of E(2) on embryonic implantation is due to a direct effect on the endometrium, on the embryo, or both.
Design: Prospective, controlled in vitro study.
Setting: Tertiary infertility center.
Patient(s): Fertile patients in the luteal phase with histologically normal endometrium who were attending the infertility clinic as oocyte donors (n = 14).
Intervention(s): E(2) dose-response (0, 10(-8), 10(-7), 10(-6), 10(-5), and 10(-4) M) and time course (day 2 vs. day 5) experiments were performed in an in vitro embryo adhesion assay composed of human polarized endometrial epithelial cells obtained from fertile patients and mouse embryos.
Main Outcome Measure(s): Blastocyst formation rate and embryo adhesion rate.
Results: Monolayers of polarized endometrial epithelial cells expressed ERalpha at the mRNA level. The E(2) dose response of blastocysts with polarized endometrial epithelial cells (n = 235) demonstrated a progressive reduction in embryonic adhesion that was statistically significant at 10(-6) M. When polarized endometrial epithelial cells were treated alone with increasing doses of E(2) for 3 days and E(2) was then removed and blastocysts added (n = 410), embryonic adhesion was not significantly reduced, except at 10(-4) M. When 2-day mouse embryos (n = 609) were treated with increasing E(2) concentrations until day 5, the rate of blastocyst formation significantly decreased at a concentration >or= 10(-6) M, and embryonic adhesion decreased when blastocysts (n = 400) were obtained at a concentration >or= 10(-7) M. Time course experiments of embryos cultured for 2 days with polarized endometrial epithelial cells (n = 426) showed that the adhesion rate was higher at E(2) levels of 10(-7), 10(-6) and 10(-5) M compared with embryos cultured for 5 days (n = 495).
Conclusion(s): High E(2) levels are deleterious to embryo adhesion in vitro, mainly because they have a direct toxic effect on the embryo that may occur at the cleavage stage.
Humm K, Ibrahim Y, Dodge L, Hacker M, Thornton K, Penzias A J Reprod Health Med. 2024; 2(Suppl 2):S15-S18.
PMID: 39723888 PMC: 5987253. DOI: 10.1016/j.jrhm.2016.11.008.
Xiao Y, Hu Y, Lv X, Huang L, Geng L, Liao P Reprod Biol Endocrinol. 2024; 22(1):78.
PMID: 38987797 PMC: 11234746. DOI: 10.1186/s12958-024-01251-5.
Lersten I, Grau L, Jahandideh S, Devine K, Zalles L, Plosker S J Assist Reprod Genet. 2024; 41(4):893-902.
PMID: 38600428 PMC: 11052734. DOI: 10.1007/s10815-024-03062-4.
Wei J, Luo Z, Dong X, Jin H, Zhu L, Ai J J Ovarian Res. 2023; 16(1):226.
PMID: 37993915 PMC: 10664607. DOI: 10.1186/s13048-023-01294-z.
Dual trigger and the impact on oocyte quality and embryo development: a Brazilian cohort.
Kozlowski I, Rosa V, Francisquini C, Schuffner A JBRA Assist Reprod. 2023; .
PMID: 37768818 PMC: 10718541. DOI: 10.5935/1518-0557.20230048.